David M Naff
Examiner (ID: 17706)
Most Active Art Unit | 1651 |
Art Unit(s) | 1302, 1643, 1657, 1208, 1808, 1207, 1803, 1802, 1651, 2899 |
Total Applications | 2218 |
Issued Applications | 1396 |
Pending Applications | 143 |
Abandoned Applications | 679 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 11581677
[patent_doc_number] => 09636297
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'Extemporaneous care product based on a lyophilizate of microorganisms and surfactant(s) with an HLB greater than or equal to 12'
[patent_app_type] => utility
[patent_app_number] => 12/990414
[patent_app_country] => US
[patent_app_date] => 2009-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 14670
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 284
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12990414
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/990414 | Extemporaneous care product based on a lyophilizate of microorganisms and surfactant(s) with an HLB greater than or equal to 12 | Apr 27, 2009 | Issued |
Array
(
[id] => 5495454
[patent_doc_number] => 20090263482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Treatment of inflammatory bowel disease with 6-mercaptopurine'
[patent_app_type] => utility
[patent_app_number] => 12/386611
[patent_app_country] => US
[patent_app_date] => 2009-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9566
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263482.pdf
[firstpage_image] =>[orig_patent_app_number] => 12386611
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/386611 | Treatment of inflammatory bowel disease with 6-mercaptopurine | Apr 19, 2009 | Abandoned |
Array
(
[id] => 6517939
[patent_doc_number] => 20100261737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'Method of Treating Erectile Dysfunction'
[patent_app_type] => utility
[patent_app_number] => 12/421768
[patent_app_country] => US
[patent_app_date] => 2009-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2573
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20100261737.pdf
[firstpage_image] =>[orig_patent_app_number] => 12421768
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421768 | Method of Treating Erectile Dysfunction | Apr 9, 2009 | Abandoned |
Array
(
[id] => 6046868
[patent_doc_number] => 20110206739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE PREPARATION OF NANOEMULSIONS'
[patent_app_type] => utility
[patent_app_number] => 12/935180
[patent_app_country] => US
[patent_app_date] => 2009-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 22943
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20110206739.pdf
[firstpage_image] =>[orig_patent_app_number] => 12935180
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/935180 | COMPOSITIONS AND METHODS FOR THE PREPARATION OF NANOEMULSIONS | Mar 29, 2009 | Abandoned |
Array
(
[id] => 6328585
[patent_doc_number] => 20100197790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'CONTAINER FOR PHARMACEUTICAL USE FOR THE QUANTITATIVE RELEASE OF A SINGLE DOSE FOR ORAL ADMINISTRATION OF T3 AND T4 THYROID HORMONES IN SOLUTION'
[patent_app_type] => utility
[patent_app_number] => 12/388691
[patent_app_country] => US
[patent_app_date] => 2009-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3778
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197790.pdf
[firstpage_image] =>[orig_patent_app_number] => 12388691
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/388691 | CONTAINER FOR PHARMACEUTICAL USE FOR THE QUANTITATIVE RELEASE OF A SINGLE DOSE FOR ORAL ADMINISTRATION OF T3 AND T4 THYROID HORMONES IN SOLUTION | Feb 18, 2009 | Abandoned |
Array
(
[id] => 5473110
[patent_doc_number] => 20090246276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'Pharmaceutical Compositions'
[patent_app_type] => utility
[patent_app_number] => 12/360673
[patent_app_country] => US
[patent_app_date] => 2009-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 73
[patent_no_of_words] => 55462
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246276.pdf
[firstpage_image] =>[orig_patent_app_number] => 12360673
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/360673 | Pharmaceutical Compositions | Jan 26, 2009 | Abandoned |
Array
(
[id] => 11217665
[patent_doc_number] => 09445984
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-20
[patent_title] => 'Two-part cosmetic product with swelling effect to biological surfaces'
[patent_app_type] => utility
[patent_app_number] => 12/866971
[patent_app_country] => US
[patent_app_date] => 2009-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5812
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 231
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12866971
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/866971 | Two-part cosmetic product with swelling effect to biological surfaces | Jan 21, 2009 | Issued |
Array
(
[id] => 5379292
[patent_doc_number] => 20090191131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'USE OF PARTICULATE CONTRAST AGENTS IN DIAGNOSTIC IMAGING FOR STUDYING PHYSIOLOGICAL PARAMATERS'
[patent_app_type] => utility
[patent_app_number] => 12/354275
[patent_app_country] => US
[patent_app_date] => 2009-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19660
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191131.pdf
[firstpage_image] =>[orig_patent_app_number] => 12354275
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/354275 | USE OF PARTICULATE CONTRAST AGENTS IN DIAGNOSTIC IMAGING FOR STUDYING PHYSIOLOGICAL PARAMATERS | Jan 14, 2009 | Abandoned |
Array
(
[id] => 6479408
[patent_doc_number] => 20100285152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'COMPOSITION FOR IMPROVING LIVER METABOLISM AND DIAGNOSTIC METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/811266
[patent_app_country] => US
[patent_app_date] => 2008-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5561
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20100285152.pdf
[firstpage_image] =>[orig_patent_app_number] => 12811266
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811266 | COMPOSITION FOR IMPROVING LIVER METABOLISM AND DIAGNOSTIC METHOD | Dec 30, 2008 | Abandoned |
Array
(
[id] => 5355585
[patent_doc_number] => 20090186929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'Method and agent for inducing apoptosis/cell death in leukemia cells'
[patent_app_type] => utility
[patent_app_number] => 12/318349
[patent_app_country] => US
[patent_app_date] => 2008-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15123
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186929.pdf
[firstpage_image] =>[orig_patent_app_number] => 12318349
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/318349 | Method and agent for inducing apoptosis/cell death in leukemia cells | Dec 28, 2008 | Abandoned |
Array
(
[id] => 5342319
[patent_doc_number] => 20090180969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'PHARMACEUTICAL FORMULATION COMPRISING AN ANTICHOLINERGIC DRUG'
[patent_app_type] => utility
[patent_app_number] => 12/343931
[patent_app_country] => US
[patent_app_date] => 2008-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5897
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20090180969.pdf
[firstpage_image] =>[orig_patent_app_number] => 12343931
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/343931 | PHARMACEUTICAL FORMULATION COMPRISING AN ANTICHOLINERGIC DRUG | Dec 23, 2008 | Abandoned |
Array
(
[id] => 6493577
[patent_doc_number] => 20100285960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => ' METHOD FOR MODULATING THE RELEASE RATE OF MICROENCAPSULATED ACTIVES'
[patent_app_type] => utility
[patent_app_number] => 12/811515
[patent_app_country] => US
[patent_app_date] => 2008-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6163
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20100285960.pdf
[firstpage_image] =>[orig_patent_app_number] => 12811515
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/811515 | METHOD FOR MODULATING THE RELEASE RATE OF MICROENCAPSULATED ACTIVES | Dec 22, 2008 | Abandoned |
Array
(
[id] => 5484863
[patent_doc_number] => 20090274628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'RECONSTITUTABLE MICROSPHERE COMPOSITIONS USEFUL AS ULTRASONIC CONTRAST AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/329202
[patent_app_country] => US
[patent_app_date] => 2008-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9001
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20090274628.pdf
[firstpage_image] =>[orig_patent_app_number] => 12329202
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/329202 | RECONSTITUTABLE MICROSPHERE COMPOSITIONS USEFUL AS ULTRASONIC CONTRAST AGENTS | Dec 4, 2008 | Abandoned |
Array
(
[id] => 6125622
[patent_doc_number] => 20110086080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'EX-VIVO PRODUCTION OF HUMAN DEMINERALIZED BONE MATRIX'
[patent_app_type] => utility
[patent_app_number] => 12/742810
[patent_app_country] => US
[patent_app_date] => 2008-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8967
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086080.pdf
[firstpage_image] =>[orig_patent_app_number] => 12742810
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/742810 | EX-VIVO PRODUCTION OF HUMAN DEMINERALIZED BONE MATRIX | Nov 13, 2008 | Abandoned |
Array
(
[id] => 6340504
[patent_doc_number] => 20100247604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'METHOD OF TREATMENT OF CONNECTIVE TISSUES AND ORGANS AND USES OF SAID TISSUES AND ORGANS'
[patent_app_type] => utility
[patent_app_number] => 12/738501
[patent_app_country] => US
[patent_app_date] => 2008-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2980
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247604.pdf
[firstpage_image] =>[orig_patent_app_number] => 12738501
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/738501 | METHOD OF TREATMENT OF CONNECTIVE TISSUES AND ORGANS AND USES OF SAID TISSUES AND ORGANS | Oct 15, 2008 | Abandoned |
Array
(
[id] => 5447118
[patent_doc_number] => 20090048344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'Pharmaceutical composition comprising 5-methyl-2-2\' (chloro-6\'-fluoroanilino phe nylacetic acid'
[patent_app_type] => utility
[patent_app_number] => 12/287231
[patent_app_country] => US
[patent_app_date] => 2008-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1811
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20090048344.pdf
[firstpage_image] =>[orig_patent_app_number] => 12287231
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/287231 | Pharmaceutical composition comprising 5-methyl-2-2' (chloro-6'-fluoroanilino phe nylacetic acid | Oct 6, 2008 | Abandoned |
Array
(
[id] => 15068287
[patent_doc_number] => 10463609
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-05
[patent_title] => Dendrimers for sustained release of compounds
[patent_app_type] => utility
[patent_app_number] => 12/681516
[patent_app_country] => US
[patent_app_date] => 2008-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 48
[patent_no_of_words] => 19781
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681516
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681516 | Dendrimers for sustained release of compounds | Oct 5, 2008 | Issued |
Array
(
[id] => 6494918
[patent_doc_number] => 20100286038
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'FORMULATION CONTAINING CYCLIN-DEPENDENT KINASE INHIBITING COMPOUND AND METHOD OF TREATING TUMORS USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/678320
[patent_app_country] => US
[patent_app_date] => 2008-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12099
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286038.pdf
[firstpage_image] =>[orig_patent_app_number] => 12678320
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/678320 | FORMULATION CONTAINING CYCLIN-DEPENDENT KINASE INHIBITING COMPOUND AND METHOD OF TREATING TUMORS USING THE SAME | Sep 15, 2008 | Abandoned |
Array
(
[id] => 5272132
[patent_doc_number] => 20090075908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'Agent For Strengthening Calcium Containing Tissue and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/210587
[patent_app_country] => US
[patent_app_date] => 2008-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8905
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20090075908.pdf
[firstpage_image] =>[orig_patent_app_number] => 12210587
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/210587 | Agent for strengthening calcium containing tissue and use thereof | Sep 14, 2008 | Issued |
Array
(
[id] => 6505893
[patent_doc_number] => 20100260856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-14
[patent_title] => 'CORE PARTICLE FOR PHARMACEUTICAL PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 12/745851
[patent_app_country] => US
[patent_app_date] => 2008-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8116
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0260/20100260856.pdf
[firstpage_image] =>[orig_patent_app_number] => 12745851
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/745851 | Core particle for pharmaceutical preparation | Sep 7, 2008 | Issued |